CrushSCI.com
85.9平均天数
64中位天数
34最短天数
176最长天数
3742025发文量

Paper Review Records

全部论文审稿周期

14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

176 天

FABP4+ macrophages promote glycolysis in lung cancer progression through the TNF-α–MYC pathway

作者
Lingwei Liu; Weibin Shu; Chuanxi Wang; Qiang Wen; Hongchang Shen; Qiang Li; Keying Che展开收起
作者单位
1. Department of Nuclear Medicine, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China; 2. Tumor Research and Therapy Center, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China展开收起
官方全文证据 DOI 网页
149 天

Dendritic cells enhance tebentafusp-mediated T cell effector responses

作者
Manuel Wiesinger; Anne Petzold; Markus Luber; Philipp Hilgendorf; Andreas Wild; Markus Vincent Heppt; Beatrice Schuler‐Thurner; Kilian Schober; Carola Berking; Elias A. T. Koch展开收起
作者单位
1. Friedrich-Alexander-Universität Erlangen-Nürnberg; 2. Universitätsklinikum Erlangen; 3. Comprehensive Cancer Center Erlangen展开收起
PDF源文件 DOI 网页
34 天

Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis

作者
K. E. Blethen; C. P. Wolford; G. L. Pecar; T. A. Arsiwala; E. Adjeroh; L. P. Dykstra; B. N. Kielkowski; P. R. Lockman展开收起
作者单位
1. Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, USA; 2. Rockefeller Neuroscience Institute, West Virginia University, Morgantown, USA展开收起
PDF源文件 DOI 网页
134 天

Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma

作者
Feihua Chen; Mouchun Gong; Dengcheng Weng; Zhaoqing Jin; Guofeng Han; Ziqiang Yang; Junjun Han; Jianjiang Wang展开收起
作者单位
1. Department of General Surgery, Hangzhou Medical College Affiliated Lin’an People’s Hospital, Hangzhou, China展开收起
PDF源文件 DOI 网页
34 天

Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment

作者
Joanna Baginska; Allison Nau; Ilana Gomez Diaz; Anita Giobbie-Hurder; Jason Weirather; Juliana Vergara; Charlotte Abrecht; Margaret Hallisey; Jenna Dennis; Mariano Severgnini; Julia Huezo; Isabella Marciello; Osama Rahma; Michael Manos; Andrew S. Brohl; Philippe L. Bedard; Daniel J. Renouf; Elad Sharon; Howard Streicher; Patrick A. Ott; Elizabeth I. Buchbinder; F. Stephen Hodi展开收起
作者单位
1. Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, USA; 2. Department of Data Science, Dana-Farber Cancer Institute, Boston, USA; 3. Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA; 4. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 5. Cancer and Department of Medicine, University of British Columbia, Vancouver, Canada; 6. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA展开收起
PDF源文件 DOI 网页
35 天

Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice

作者
Akashdip Singh; Eline T. A. M. Mommers-Elshof; Saskia V. Vijver; J. H. Marco Jansen; Susanne Gonder; Robert Jan Lebbink; Dominique Bihan; Richard W. Farndale; Louis Boon; Solomon Langermann; Jeanette H. W. Leusen; Dallas Flies; Linde Meyaard; M. Ines Pascoal Ramos展开收起
作者单位
1. Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands; 2. Oncode Institute, Utrecht, The Netherlands; 3. Department of Biochemistry, University of Cambridge, Cambridge, UK; 4. JJP Biologics, Warsaw, Poland; 5. Nextcure, Beltsville, USA展开收起
PDF源文件 DOI 网页

FAQ

CANCER IMMUNOLOGY IMMUNOTHERAPY审稿要多久?

截至2026-11-19,CrushSCI 收录了 CANCER IMMUNOLOGY IMMUNOTHERAPY 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 34 天(Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis,2023-10-03 收稿,2023-11-06 录用),最慢一篇用了 176 天;平均 85.9 天,中位数 64 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。